id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-0265-0008,FDA,FDA-2014-E-0265,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:00:31Z,,0,0,090000648243db42
FDA-2014-E-0265-0007,FDA,FDA-2014-E-0265,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2016-08-01T04:00:00Z,2016,8,2016-08-01T04:00:00Z,,2016-08-02T01:56:02Z,,0,0,090000648214b312
FDA-2014-E-0265-0006,FDA,FDA-2014-E-0265,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2015-12-28T05:00:00Z,2015,12,2015-12-28T05:00:00Z,,2015-12-28T16:07:11Z,,0,0,0900006481dd40cf
FDA-2014-E-0265-0005,FDA,FDA-2014-E-0265,"Determination of Regulatory Review Period for Purposes of Patent
Extension; SIRTURO",Notice,Determinations,2015-12-10T05:00:00Z,2015,12,2015-12-10T05:00:00Z,2016-02-09T04:59:59Z,2015-12-10T16:59:04Z,2015-31098,0,0,0900006481d9ac0e
FDA-2014-E-0265-0004,FDA,FDA-2014-E-0265,Letter from the U.S. Patent and Trademark Office to FDA,Other,Letter(s),2015-03-25T04:00:00Z,2015,3,2015-03-25T04:00:00Z,,2015-03-25T16:48:33Z,,0,0,0900006481a64247
FDA-2014-E-0265-0003,FDA,FDA-2014-E-0265,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2014-03-27T04:00:00Z,2014,3,2014-03-27T04:00:00Z,,2014-03-27T14:52:11Z,,0,0,0900006481686bb1
FDA-2014-E-0265-0002,FDA,FDA-2014-E-0265,"Patent Extention from Johnson & Johnson (Janssen Pharmaceutica, N.V.)",Other,Application,2014-03-05T05:00:00Z,2014,3,2014-03-05T05:00:00Z,,2014-03-05T19:41:01Z,,0,0,09000064815fcd15
FDA-2014-E-0265-0001,FDA,FDA-2014-E-0265,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2014-03-05T05:00:00Z,2014,3,2014-03-05T05:00:00Z,,2014-03-05T19:40:36Z,,0,0,09000064815fcd16